These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6384962)

  • 1. [Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1984 Apr; 39(15):501-3. PubMed ID: 6384962
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative trial of combined oxprenolol-chlorthalidone and a beta-blockader and diuretic separately in primary arterial hypertension].
    Luna RL; Faerchtein I; de Vasconcelos EM; Arslanian L; de La Nuez SB; Pereira WQ; Puppin S; Campos JC; Roque AF; Kastansky I
    Arq Bras Cardiol; 1979 Oct; 33(4):311-20. PubMed ID: 398212
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Slow-release oxprenolol and chlortalidone administered once daily in essential hypertension].
    Rossi A; Ziacchi V; Fracalossi C; Marino A; Lomanto B
    Minerva Cardioangiol; 1984 Dec; 32(12):949-62. PubMed ID: 6531101
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
    Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
    G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
    [No Abstract]   [Full Text] [Related]  

  • 6. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Toso M; Valori C; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 8. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
    Masoni A; Tomasi AM; Pirani R; Lazzaretto R; Ambroso G
    G Ital Cardiol; 1981; 11(12):2105-9. PubMed ID: 7346306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day].
    Fariello R; Alicandri C; Boni E; Montini E; Zaninelli A; Agabiti-Rosei E; Motolese M; Muiesan G
    G Ital Cardiol; 1984 Feb; 14(2):121-6. PubMed ID: 6714549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertension with a new combination of beta blocking agents and saluretics].
    Deibert K
    Med Welt; 1980 Sep; 31(36):1288-90. PubMed ID: 7442528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of long term oxprenolol and chlorthalidone singly and in combination in hypertensive blacks.
    Obel AO
    Jpn Heart J; 1990 Mar; 31(2):183-92. PubMed ID: 2192098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effects of oxprenolol and nifedipine on blood pressure at rest and during physical exercise in essential hypertension].
    Gambini G; Pizzuti C; Valori C
    Clin Ter; 1988 Feb; 124(3):203-10. PubMed ID: 2974332
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive effect of oxprenolol and chlorthalidone in fixed combination, given once daily.
    Buoninconti R; Motolese M; Rubegni M
    J Int Med Res; 1979; 7(6):519-23. PubMed ID: 391625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of arterial hypertension with a delayed-action clonidine and chlorthalidone combination].
    Scali G; Del Vita M; Bompani R
    Clin Ter; 1985 Apr; 113(2):111-6. PubMed ID: 4017490
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    Baronchelli A; Agosta R; Verdecchia P; Bichisao E
    Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of long-term antihypertensive therapy with tenoretic--a combined long-acting drug].
    Ivashkin VT; Grigor'ev IuV; Sinopal'nikov AI
    Klin Med (Mosk); 1990 Jul; 68(7):70-2. PubMed ID: 2232654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of low clonidine doses in galenic sustained-release preparations. Study with Combipresan 75 perlongettes].
    Bibracher C; Podzich M
    MMW Munch Med Wochenschr; 1982 May; 124(18):457-8. PubMed ID: 6808370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trials with clonidine-chlorthalidone, a combined preparation in the treatment of hypertensive diseases].
    Dejaco RM; Hartl O
    Wien Med Wochenschr; 1973 Feb; 123(7):96-9. PubMed ID: 4631628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.